Cardinal Health raised its annual outlook again after logging higher profit and revenue in its fiscal second quarter.

The pharmaceutical distributor and health services company raises its guidance for the second time.

By Padmanabhan Ananthan Feb 5 (Reuters) - Cardinal Health on Thursday raised its 2026 profit outlook after beating quarterly ...

The team remains focused on driving Cardinal Health brand growth, where we continue to see positive results and ...

Cardinal Health has reported that revenue for its Other segment, which includes at-Home Solutions, increased 34% to $1.7 ...

Cardinal Health's second-quarter earnings might have been driven by Pharma and Specialty Solutions, as strong utilization and GLP-1 momentum must have raised revenues and EPS.

Cardinal Health reports strong Q2 results and raises fiscal 2026 outlook. Sales increased by 19%, beating estimates.

Pharmaceutical distributor Cardinal Health is eyeing an expanded footprint in the specialty medicine space through the planned acquisitions of GI Alliance (GIA) and Advanced Diabetes Supply Group (DSG ...

Cardinal Health, Inc. (NYSE:CAH) supplies branded, generic, and specialty medicines and provides pharmacy and specialty drug ...

Cardinal Health stock reached an all-time high of $229.87, marking a significant milestone for the company. Over the past year, the stock has experienced a remarkable 80.15% incre ...

The Columbus Zoo and Aquarium has appointed Stacey Burbure of AEP and Jessica Mayer of Cardinal Health to its board, adding leadership to support the zoo’s mission.

Target, CVS and Rite Aid are pulling products from shelves after federal investigators found unsanitary conditions and recommended a recall. By Rebecca Carballo An agreement between attorneys general ...